MedTrace Logo

Post Marketing Observational Study of Reformulated BeneFIX

NCT00835068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2014-09-17

Study results available
· View outcomes & findings →

Summary

The primary objective of this observational study is to collect safety data on reformulated BeneFIX as prescribed in routine clinical practice conditions in France. The secondary objectives are to collect data on the clinical course of individuals treated with reformulated BeneFIX and on the ease of reformulated BeneFIX.

Conditions

  • Hemophilia B

Interventions

OTHER

No intervention

As it is a non interventional study, patient receives his usual treatment (BeneFIX) as determined by the physician

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835068 on ClinicalTrials.gov